drug

ABBV-253

1 story · latest Sep 10, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie sponsors new ABBV-253 solid tumor trial; collaborates on epcoritamab lymphoma study

Sep 10Weekly roundup, 2 itemsABBV-253 AbbVie

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.